In colorectal cancer, it has been demonstrated that treatment with extracts from Sageretia thea, a medicinal plant used for treating hepatitis and fevers in Korea and China, decreases cell viability by inducing GSK3β-dependent cyclin D1 degradation and increasing HO-1 expression via activation of Nrf2 [227]. Here, HMOX1 is linked to colorectal cancer.